Key facts
- It has raised $62.1M; the latest was Later Stage VC in Sep 2024.
- Notable investors include FJ Labs, 8VC, Abstract Ventures, University of Toronto Entrepreneurship, FundersClub — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Vital Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Vital Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vital Bio
Developer of advanced diagnostic technologies designed to bridge the gap between diagnosis and treatment. The company's technology offers an ecosystem of devices, software, and services that aim to make healthcare radically more personalized, proactive, and accessible, enabling clinicians to reduce inequality of well-being, redistribute control to patients, and empower healthcare providers to create better outcomes.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2016
- Employees
- 193
- Website
- vitalbio.com/
- Ownership
- Privately Held (backing)
Vital Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vital Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vital Bio in its N-PORT filings yet. We sweep new filings monthly.